Trial Profile
Safety and Efficacy of Sunitinib Given in Schedule Modification in Patients with Advanced Renal Cell Carcinoma (RCC)
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 05 Sep 2013 New trial record